Table 3

Breakthrough and 24-hour dosing characteristics

BupivacaineRopivacaine
AllPVBTAPAllPVBTAP
24-hour breakthrough dosing
 Breakthrough mean (mg/kg)0.14 (0.03–1.3) n=3850.14 (0.03–1.3) n=3540.29 (0.25–0.45) n=310.27 (0.05–2.3), n=11090.43 (0.05–2.3), n=9960.14 (0.06–0.3), n=113
 Breakthrough max (mg/kg)0.29 (0.07–2.8) n=3850.29 (0.07–2.8) n=3540.29 (0.25–0.9) n=311.7 (0.12–7.2), n=11091.5 (0.1–7.2), n=9963.1 (0.15–6.9), n=113
24-hour total doses (Bolus, infusion and breakthrough)
 Median 24-hour dose (mg/kg)6 (2.1–13.6)
N=3223
6.1 (2.5–13.6) n=27004 (1.5–10) n=5237.75 (2.1–15.7), n=35797.3 (2.1–15.9), n=30608.0 (2.2–15.1), n=519
 IQR (mg/kg)4.1–9.65.0–9.63.2–6.86.1–11.15.8–11.17.7–12.4
 Mean±SD (mg/kg)6.6±3.27.0±3.24.7±2.28.4±3.88.3±3.89.0±3.5
  • Unless otherwise specified, data presented as median (95% CI), n.

  • PVB, paravertebral; TAP, Transversus abdominis plane.